You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

Article info

Article menu

Download PDFPDF

Research Article
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

Authors

  • Renee N. Donahue Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Lauren M. Lepone Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Italia Grenga Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Caroline Jochems Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Massimo Fantini Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Ravi A. Madan Genitourinary Malignancies Branch, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Christopher R. Heery Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  • James L. Gulley Genitourinary Malignancies Branch, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Jeffrey Schlom Laboratory of Tumor Immunology and Biology, Center for Cancer ResearchNational Cancer Institute, National Institutes of Health 10 Center Drive, Room 8B09 Bethesda MD USA PubMed articlesGoogle scholar articles
  1. ↵a renee.donahue{at}nih.gov
  2. ↵b lmlepone{at}gmail.com
  3. ↵c italia.grenga{at}nih.gov
  4. ↵d jochemscm{at}mail.nih.gov
  5. ↵e kurk84{at}gmail.com
  6. ↵f madanr{at}mail.nih.gov
  7. ↵g chhe{at}bavarian-nordic.com
  8. ↵h gulleyj{at}mail.nih.gov
  9. ↵i js141c{at}nih.gov
View Full Text

Citation

Donahue RN, Lepone LM, Grenga I, et al
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
Journal for ImmunoTherapy of Cancer 2017;5:20. doi: 10.1186/s40425-017-0220-y

Publication history

  • Received November 7, 2016
  • Accepted February 1, 2017
  • First published February 21, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.